These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 11029876)

  • 1. [Positron emission tomography in pharmacokinetics and pharmacodynamics].
    Lucignani G; Moresco RM; Fazio F
    Boll Chim Farm; 1993; 132(7):231-3. PubMed ID: 8398055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
    Bruschini P; Giorgetti A; Bruschini L; Nacci A; Volterrani D; Cosottini M; Ursino F; Mariani G; Fattori B
    Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):446-53. PubMed ID: 15198047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
    Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
    Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET and drug research and development.
    Fowler JS; Volkow ND; Wang GJ; Ding YS; Dewey SL
    J Nucl Med; 1999 Jul; 40(7):1154-63. PubMed ID: 10405137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in drug development.
    Rubin RH; Fischman AJ
    Q J Nucl Med; 1997 Jun; 41(2):171-5. PubMed ID: 9203856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symposium: New methods of research in clinical pharmacology. Paris, 19-20 March 1987. Abstracts].
    Therapie; 1987; Suppl():81-165. PubMed ID: 3495046
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of radioactive decay and their implications on in vivo metabolic imaging.
    Kouris K; Jackson DF
    Am J Physiol Imaging; 1987; 2(1):44-7. PubMed ID: 3502528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dedicated small animal scanners: a new tool for drug development?
    Hume SP; Myers R
    Curr Pharm Des; 2002; 8(16):1497-511. PubMed ID: 12052208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical discovery and development: nuclear and molecular imaging technologies recognized.
    Katz J
    J Nucl Med; 1999 Jul; 40(7):22N-23N, 26N. PubMed ID: 10405122
    [No Abstract]   [Full Text] [Related]  

  • 13. PET in drug discovery and development: an introduction.
    Scheinin H; Scheinin M; Knuuti J
    Ann Med; 1999 Dec; 31(6):430-1. PubMed ID: 10680857
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear magnetic resonance in clinical pharmacology and measurement of therapeutic response.
    Aellig WH
    Br J Clin Pharmacol; 1990 Feb; 29(2):157-67. PubMed ID: 2407281
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thoughts on clinical pharmacology].
    Modr Z
    Cas Lek Cesk; 1988 Jun; 127(23):710-4. PubMed ID: 3401903
    [No Abstract]   [Full Text] [Related]  

  • 16. Constant temperature apparatus for increasing the solubility of drugs for injection.
    EASTERDAY OD
    Arch Int Pharmacodyn Ther; 1957 Oct; 112(1-2):50-6. PubMed ID: 13498837
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of imaging as biomarkers in drug development: regulatory issues worldwide.
    Katz R; Wagner HN; Fauntleroy M; Kuwert T; Frank R
    J Clin Pharmacol; 2001 Jul; 41(S7):118S. PubMed ID: 11452719
    [No Abstract]   [Full Text] [Related]  

  • 18. A simple device for recording the action of drugs on motility of rats.
    SCHUTZ F
    J Physiol; 1946 Jul; 105():20. PubMed ID: 20994092
    [No Abstract]   [Full Text] [Related]  

  • 19. Positron emission tomography: from production and distribution to drug research and clinical applications.
    Coleman RE; Bednarczyk EM; Chilton H
    J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S66-7. PubMed ID: 11029876
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.